Tele-medicine controlled hospital at home is associated with better outcomes than hospital stay
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0309077 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Noa Zychlinski und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Data and Decision Sciences, Technion-Israel Institute of Technology, Haifa, Israel. Hauptthemen laut MEDLINE: COVID-19, Length of Stay, Telemedicine. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technology and Space.
Abstract (Originalsprache)
Background
Hospital-at-home (HAH) is increasingly becoming an alternative for in-hospital stay in selected clinical scenarios. Nevertheless, there is still a question whether HAH could be a viable option for acutely ill patients, otherwise hospitalized in departments of general-internal medicine.
Methods
This was a retrospective matched study, conducted at a telemedicine controlled HAH department, being part of a tertiary medical center. The objective was to compare clinical outcomes of acutely ill patients (both COVID-19 and non-COVID) admitted to either in-hospital or HAH. Non-COVID patients had one of three acute infectious diseases: urinary tract infections (UTI, either lower or upper), pneumonia, or cellulitis.
Results
The analysis involved 159 HAH patients (64 COVID-19 and 95 non-COVID) who were compared to a matched sample of in-hospital patients (192 COVID-19 and 285 non-COVID). The median length-of-hospital stay (LOS) was 2 days shorter in the HAH for both COVID-19 patients (95% CI: 1–3; p = 0.008) and non-COVID patients (95% CI; 1–3; p < 0.001). The readmission rates within 30 days were not significantly different for both COVID-19 patients (Odds Ratio (OR) = 1; 95% CI: 0.49–2.04; p = 1) and non-COVID patients (OR = 0.7; 95% CI; 0.39–1.28; p = 0.25). The differences remained insignificant within one year. The risk of death within 30 days was significantly lower in the HAH group for COVID-19 patients (OR = 0.34; 95% CI: 0.11–0.86; p = 0.018) and non-COVID patients (OR = 0.38; 95% CI: 0.14–0.9; p = 0.019). For one year survival period, the differences were significant for COVID-19 patients (OR = 0.5; 95% CI: 0.31–0.9; p = 0.044) and insignificant for non-COVID patients (OR = 0.63; 95% CI: 0.4–1; p = 0.052).
Conclusions
Care for acutely ill patients in the setting of telemedicine-based hospital at home has the potential to reduce hospitalization length without increasing readmission risk and to reduce both 30 days and one-year mortality rates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Faculty of Data and Decision Sciences, Technion-Israel Institute of Technology, Haifa, Israel.
- Biostatistics and Biomathematics Unit, Gertner Institute of Epidemiology and Health Policy Research, Chaim Sheba Medical Center, Tel Hashomer, Israel.
- Sheba Beyond Virtual Hospital, Chaim Sheba Medical Center, Ramat Gan, Israel.
- Management Wing, Chaim Sheba Medical Center, Ramat Gan, Israel.
- Education Authority, Chaim Sheba Medical Center, Ramat Gan, Israel.
- Faculty of Healthcare and Medicine, Tel Aviv University, Tel-Aviv, Israel.
ORCID-Profile: Gad Segal
Förderung
- Ministry of Science, Technology and Space
Zitieren
APA
Zychlinski, N., Fluss, R., Goldberg, Y., Zubli, D., Barkai, G., Zimlichman, E., & Segal, G. (2024). Tele-medicine controlled hospital at home is associated with better outcomes than hospital stay. PLOS ONE. https://doi.org/10.1371/journal.pone.0309077
Vancouver
Zychlinski N, Fluss R, Goldberg Y, Zubli D, Barkai G, Zimlichman E, et al. Tele-medicine controlled hospital at home is associated with better outcomes than hospital stay. PLOS ONE. 2024. doi:10.1371/journal.pone.0309077
BibTeX
@article{Zychlinski2024,
author = {Zychlinski, Noa and Fluss, Ronen and Goldberg, Yair and Zubli, Daniel and Barkai, Galia and Zimlichman, Eyal and Segal, Gad},
title = {Tele-medicine controlled hospital at home is associated with better outcomes than hospital stay},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0309077}
}
EUVIMED